Mutation explains relapse on EGFR products 1 September 2005 Drug Watch 0 Number 7 Download pdf article A discovery made simultaneously by two groups of US researchers may help lung cancer patients who relapse after an initial response to novel targeted therapies. Download full article EGFRLung cancerT790M
